No results.

Aastrom Biosciences

Founded in 1989 and with headquarters in Ann Arbor, Michigan, Aastrom Biosciences is dedicated to the development of treatments for critical cardiovascular diseases. Aastrom is currently evaluating its autologous cellular therapies in late-stage U.S. clinical trials in the treatment of critical limb ischemia (CLI) and dilated cardiomyopathy (DCM). These critical diseases are associated with significant morbidity and mortality and very limited treatment options.

Living with Critical Limb Ischemia

In this video, Rosemary and Dick Hough talk about the detrimental effects of critical limb ischemia. To learn more about CLI, visit